HRT Financial’s IDEAYA Biosciences IDYA Stock Holding History

HRT Financial’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,368	Closed	-$282K	–	3554
2025 Q3	$282K	Sell	10,368 -6,528	-39%	-$158K	﹤0.01%	2207
2025 Q2	$355K	Sell	16,896 -4,324	-20%	-$83K	﹤0.01%	1769
2025 Q1	$347K	Buy	+21,220	New	+$452K	﹤0.01%	1694
2024 Q4	–	Sell	-20,405	Closed	-$646K	–	2782
2024 Q3	$646K	Buy	+20,405	New	+$774K	﹤0.01%	1464
2023 Q2	–	Sell	-42,537	Closed	-$584K	–	2824
2023 Q1	$584K	Buy	+42,537	New	+$709K	0.01%	1251
2022 Q4	–	Sell	-40,834	Closed	-$609K	–	2766
2022 Q3	$609K	Buy	+40,834	New	+$530K	0.01%	1307
2022 Q2	–	Sell	-65,226	Closed	-$729K	–	3271
2022 Q1	$729K	Buy	+65,226	New	+$961K	0.01%	1348

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

HRT Financial's IDYA Position: Q4 2025 in Review

HRT Financial sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 10,368 shares — an estimated $282K sold.

HRT Financial first reported a position in IDYA in Q1 2022 and held it in 7 quarters. The position peaked at $729K in Q1 2022. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

HRT Financial reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
HRT Financial sold 10,368 IDEAYA Biosciences shares in Q4 2025, an estimated $282K.
HRT Financial first reported a position in IDEAYA Biosciences in Q1 2022 and held it in 7 quarters.
HRT Financial's IDEAYA Biosciences position peaked at $729K in Q1 2022.
246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.